adiposity insulin resistance humans role tissue cellular lipid depots pubmed ncbi abstract human adiposity long insulin resistance increased cardiovascular risk abdominal adiposity considered adverse intra-abdominal fat insulin resistance possibly mediated greater lipolytic activity lower adiponectin levels resistance leptin increased inflammatory cytokines contribution clear liver lipid closely important contributor insulin resistance part consequence lipogenic pathway insulin action up-regulated hyperinsulinemia unimpaired signaling intramyocellular triglyceride muscle insulin resistance anomalies include higher intramyocellular triglyceride insulin-sensitive athletes women men issues explained culprits active lipid moieties diacylglycerol ceramide species dependent lipid metabolism partitioning triglyceride amount subcutaneous fat gluteofemoral appears metabolically protective illustrated insulin resistance dyslipidemia patients lipodystrophy studies suggest deep sc abdominal fat adverse properties pericardial perivascular fat relate atheromatous disease insulin resistance recent interest recognizable brown adipose tissue adult humans augmentation hormone irisin exercising muscle brown adipose tissue metabolically active oxidizes fatty acids generates heat small variable quantities metabolic importance humans usual living conditions unclear understanding specific roles lipid depots approaches control obesity metabolic sequelae 
